Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation.

Guardat en:
Dades bibliogràfiques
Publicat a:J Biol Chem
Autors principals: Weider, Elodie, Susan-Resiga, Delia, Essalmani, Rachid, Hamelin, Josée, Asselin, Marie-Claude, Nimesh, Surendra, Ashraf, Yahya, Wycoff, Keith L., Zhang, Jianbing, Prat, Annik, Seidah, Nabil G.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2016
Matèries:
Additions and Corrections
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159516/
https://ncbi.nlm.nih.gov/pubmed/27986868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.A116.717736
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars